These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 17085323)

  • 1. Effects of selective PGE2 receptor antagonists in esophageal adenocarcinoma cells derived from Barrett's esophagus.
    Piazuelo E; Jiménez P; Strunk M; Santander S; García A; Esteva F; Lanas A
    Prostaglandins Other Lipid Mediat; 2006 Dec; 81(3-4):150-61. PubMed ID: 17085323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostaglandin EP2 receptor expression is increased in Barrett's oesophagus and oesophageal adenocarcinoma.
    Jiménez P; Piazuelo E; Cebrian C; Ortego J; Strunk M; García-Gonzalez MA; Santander S; Alcedo J; Lanas A
    Aliment Pharmacol Ther; 2010 Feb; 31(3):440-51. PubMed ID: 19843025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inhibition of cyclooxygenase-2 suppresses growth and induces apoptosis in human esophageal adenocarcinoma cells.
    Souza RF; Shewmake K; Beer DG; Cryer B; Spechler SJ
    Cancer Res; 2000 Oct; 60(20):5767-72. PubMed ID: 11059772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastrin-induced cyclooxygenase-2 expression in Barrett's carcinogenesis.
    Abdalla SI; Lao-Sirieix P; Novelli MR; Lovat LB; Sanderson IR; Fitzgerald RC
    Clin Cancer Res; 2004 Jul; 10(14):4784-92. PubMed ID: 15269153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice.
    Santander S; Cebrián C; Esquivias P; Conde B; Esteva F; Jiménez P; Ortego J; Lanas A; Piazuelo E
    Int J Oncol; 2012 Feb; 40(2):527-34. PubMed ID: 21971589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NO-releasing aspirin exerts stronger growth inhibitory effect on Barrett's adenocarcinoma cells than traditional aspirin.
    Konturek PC; Kania J; Burnat G; Hahn EG
    J Physiol Pharmacol; 2006 Dec; 57 Suppl 12():15-24. PubMed ID: 17244951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest.
    Cheong E; Ivory K; Doleman J; Parker ML; Rhodes M; Johnson IT
    Carcinogenesis; 2004 Oct; 25(10):1945-52. PubMed ID: 15155531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statins inhibit proliferation and induce apoptosis in Barrett's esophageal adenocarcinoma cells.
    Ogunwobi OO; Beales IL
    Am J Gastroenterol; 2008 Apr; 103(4):825-37. PubMed ID: 18371146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyclooxygenase-2 inhibitors demonstrate anti-proliferative effects in oesophageal cancer cells by prostaglandin E(2)-independent mechanisms.
    Deasy BM; O'Sullivan-Coyne G; O'Donovan TR; McKenna SL; O'Sullivan GC
    Cancer Lett; 2007 Oct; 256(2):246-58. PubMed ID: 17707579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative and apoptotic effects of rofecoxib on esophageal cancer in vitro(1).
    Vona-Davis L; Riggs DR; Jackson BJ; McFadden DW
    J Surg Res; 2004 Jun; 119(2):143-8. PubMed ID: 15145696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective cyclooxygenase-2 inhibition suppresses basic fibroblast growth factor expression in human esophageal adenocarcinoma.
    Baguma-Nibasheka M; Barclay C; Li AW; Geldenhuys L; Porter GA; Blay J; Casson AG; Murphy PR
    Mol Carcinog; 2007 Dec; 46(12):971-80. PubMed ID: 17477358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2-derived prostaglandin e2 protects mouse embryonic stem cells from apoptosis.
    Liou JY; Ellent DP; Lee S; Goldsby J; Ko BS; Matijevic N; Huang JC; Wu KK
    Stem Cells; 2007 May; 25(5):1096-103. PubMed ID: 17234991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells.
    Lampiasi N; Foderà D; D'Alessandro N; Cusimano A; Azzolina A; Tripodo C; Florena AM; Minervini MI; Notarbartolo M; Montalto G; Cervello M
    Int J Mol Med; 2006 Feb; 17(2):245-52. PubMed ID: 16391822
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase isozymes are expressed in human myeloma cells but not involved in anti-proliferative effect of cyclooxygenase inhibitors.
    Ding J; Tsuboi K; Hoshikawa H; Goto R; Mori N; Katsukawa M; Hiraki E; Yamamoto S; Abe M; Ueda N
    Mol Carcinog; 2006 Apr; 45(4):250-9. PubMed ID: 16385588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Barret's adenocarcinoma cell growth by simvastatin: involvement of COX-2 and apoptosis-related proteins.
    Konturek PC; Burnat G; Hahn EG
    J Physiol Pharmacol; 2007 Aug; 58 Suppl 3():141-8. PubMed ID: 17901590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide stimulates the production of prostaglandin E2 and the receptor Ep4 in osteoblasts.
    Shoji M; Tanabe N; Mitsui N; Tanaka H; Suzuki N; Takeichi O; Sugaya A; Maeno M
    Life Sci; 2006 Mar; 78(17):2012-8. PubMed ID: 16289620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 upregulates survivin expression via the EP1 receptor in hepatocellular carcinoma cells.
    Bai XM; Jiang H; Ding JX; Peng T; Ma J; Wang YH; Zhang L; Zhang H; Leng J
    Life Sci; 2010 Jan; 86(5-6):214-23. PubMed ID: 20035770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of the prostaglandin E2/E-prostanoid 2 receptor signaling pathway in abscess formation in rat zymosan-induced pleurisy.
    Inada T; Arai K; Kawamura M; Hatanaka K; Sato Y; Noshiro M; Harada Y
    J Pharmacol Exp Ther; 2009 Dec; 331(3):860-70. PubMed ID: 19726696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leptin stimulates proliferation and inhibits apoptosis in Barrett's esophageal adenocarcinoma cells by cyclooxygenase-2-dependent, prostaglandin-E2-mediated transactivation of the epidermal growth factor receptor and c-Jun NH2-terminal kinase activation.
    Ogunwobi O; Mutungi G; Beales IL
    Endocrinology; 2006 Sep; 147(9):4505-16. PubMed ID: 16740977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the bile acid receptor FXR in Barrett's esophagus and enhancement of apoptosis by guggulsterone in vitro.
    De Gottardi A; Dumonceau JM; Bruttin F; Vonlaufen A; Morard I; Spahr L; Rubbia-Brandt L; Frossard JL; Dinjens WN; Rabinovitch PS; Hadengue A
    Mol Cancer; 2006 Oct; 5():48. PubMed ID: 17054793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.